Search

You searched for "presentation"

754 results found

Bladder & Bowel UK National Symposium North West

3 March 2026
The Bladder & Bowel UK National Symposium North West 2026 Supporting bladder and bowel health for everyone Join us at the Bladder & Bowel UK North West Symposium! This is an exceptional opportunity for healthcare professionals to engage with leading...

Bladder & Bowel UK Symposium in the North

3 March 2026
Supporting bladder and bowel health for everyone Join us at the Bladder & Bowel UK North West Symposium! This is an exceptional opportunity for healthcare professionals to engage with leading national experts and immerse themselves in a programme packed with...

Imaging of varicoceles

1 January 2017 | | URO - Uroradiology
A varicocele is a collection of dilated, tortuous spermatic veins of the pampiniform venous plexus. It is seen in 10-15% of the general population and is associated with both primary and secondary infertility. A varicocele is the most common cause...

The bulbocavernosus reflex

6 January 2023 | | URO - Neurourology
Despite its first discovery predating the early-1940s, clinical application of the bulbocavernosus reflex (BCR) has been limited to date. The BCR traditionally involves contraction of the bulbo- and ischiocavernosus pelvic floor muscles, often referred to as the ‘bulbocavernosus muscle’, in...

Workshop news update from the upcoming BAUN Conference at the ACC in Liverpool on 4 - 5 November

18 September 2024 | Awards, Conferences & Anniversaries, Research & Development, Urology News
The British Association of Urological Nurses (BAUN) Conference 2024 takes place from 4-5 November at the ACC in Liverpool. In addition, popular pre-conference workshops are taking place on Sunday 3 November.

Immunotherapy in renal cancer

1 May 2019 | | URO - Basic Science Research, URO - Urologic Oncology
Renal cell carcinoma (RCC) is the sixth most common solid organ cancer in the UK. In 2018, there were 403,262 people diagnosed worldwide with the disease (2.2% of all cancer cases), and it accounted for 175,098 deaths in total (1.8%...

Men with a susceptibility to prostate cancer: implications of family history in PCa risk-prediction

3 September 2021 | | URO - Urologic Oncology
Incorporation of family history (FH) status into prostate cancer (PCa) risk stratification has the potential to underpin many aspects of PCa care. This group of men presents a unique challenge in early cancer detection, particularly given that most men without...

Black men are more at risk from prostate cancer, but we won’t let it stay that way – an update from Prostate Cancer Research

4 May 2023 | | URO - Urologic Oncology
- CHARITY FOCUS - Focusing on all of disease characteristics, societal factors, and better communication gives us real potential to fix a disparity that has persisted for too long. When it comes to health inequity, the numbers are stark. Black...

The impact of menopause on bladder symptoms

11 July 2023 | | URO - Functional / Reconstructive Urology, URO - Infection
The menopause is a natural process of ageing when the ovaries completely stop producing reproductive hormones (oestrogen and other sex steroids), and there are no monthly periods for 12 consecutive months. It normally occurs between the ages of 45-55 years...

Prostate cancer management 2 – metastatic disease

2 July 2025 | | URO - Urologic Oncology, URO - Core Urology, URO - Uroradiology
A 72-year-old gentleman is referred to you in the two-week wait clinic with a prostate specific antigen (PSA) of 22ug/L. He is otherwise fit and well and does not take any regular medication. His multi-parametric magnetic resonance imaging (mpMRI) shows...

Urologist in the House!

2 March 2022 | | URO - Technology
In this series of articles I am going to show you some of the exhibits contained in the Museum of Urology, hosted on the BAUS website (www.baus.org.uk). This month, I am joined once again by Kassie Ball to discuss the...

Supporting Patients Receiving Hormone Therapy: Introducing LiveWell

30 June 2026
Androgen deprivation therapy (ADT) is a cornerstone of prostate cancer treatment, yet up to 30% of men experience significant long-term side effects affecting physical, metabolic, and psychological wellbeing. While there is strong evidence supporting exercise, lifestyle, and psychosocial interventions, access...